RX-0201
an antisense oligonucleotide (ASO) against Akt1 currently in clinical trial for metastatic renal cancer.
Networked: 1
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
Experts
| 1. | Ahn, Chang-Ho:
1 article
(06/2018)
|
| 2. | Chen, Lihua:
1 article
(06/2018)
|
| 3. | Cheng, Xinwei:
1 article
(06/2018)
|
| 4. | Kim, Deog Joong:
1 article
(06/2018)
|
| 5. | Lee, Robert J:
1 article
(06/2018)
|
| 6. | Lee, Young B:
1 article
(06/2018)
|
| 7. | Li, Hong:
1 article
(06/2018)
|
| 8. | Liu, Qibing:
1 article
(06/2018)
|
| 9. | Liu, Yang:
1 article
(06/2018)
|
| 10. | Qi, Shanshan:
1 article
(06/2018)
|
Related Diseases
Related Drugs and Biologics